FDA Warning Letter — Morton Grove Pharmaceuticals, Inc.
The FDA took a Warning Letter action against Morton Grove Pharmaceuticals, Inc. on February 17, 2017 (Morton Grove, IL). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Morton Grove Pharmaceuticals, Inc.
- Date
- February 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Morton Grove, IL (United States)